Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548795 · ClinicalTrials.gov registry record
Viral-Related Neutrophil Response and Condition Severity in People With ARDS
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 132
- Enrollment target
NCT00548795 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 132 participants.
The verdict
NCT00548795 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
Acute respiratory distress syndrome (ARDS) is a severe lung condition that can result from a bacterial infection in the lungs. Viral infections may impair the body's immune system response to bacteria, which may lead to more serious lung injury. This study will evaluate the association between the immune response and ARDS severity in people who have ARDS plus a viral infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00548795
The ClinicalTrials.gov registry entry for NCT00548795 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00548795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00548795 about?
NCT00548795 is a clinical study titled "Viral-Related Neutrophil Response and Condition Severity in People With ARDS". Acute respiratory distress syndrome (ARDS) is a severe lung condition that can result from a bacterial infection in the lungs. Viral infections may impair the body's immune system response to bacteria, which may lead to more serious lung injury. This study will evaluate the association between the i...
What is the current status of trial NCT00548795?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2007-08. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT00548795?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.